Health Care: Drugs

Vertex Pharmaceuticals Inc (VRTX: NASDAQ)

$118.41 3.26 | 2.83%
12/26/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 115.15
52 Week High 124.35
52 Week Low 59.79
Avg. Daily Vol. (Mil) 1.68
Beta (3 year) -1.01
Share Related Items
Mkt Cap (Mil) 27,696.09
Shares Out (Mil) 240.52
Float (Mil) 209.29
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.30
Current Ratio 4.40
LT Debt/ Equity 0.70
Total Debt / Equity 0.72
Valuation Ratios
Price Earnings n.a.
Price/Sales 35.19
Price/Book 23.96
Price/Cash Flow -40.60
Per Share Data
Earnings -2.18
Sales 3.27
Book Value 4.81
Cash Flow -2.84
Business Summary
Vertex Pharmaceuticals Inc discovers, develops and commercializes small molecule drugs for the treatment of serious diseases.
General Information
50 Northern Avenue
Boston, MA 02210
www.vrtx.com
Industry : Drugs
Sector: Health Care
Employees: 1800
CEO: Dr. Jeffrey M Leiden M.D
Short Interest
Current Month (Mil) 5.32
Previous Month (Mil) 5.31
Short Interest Ratio (Days) 3.80
Management Effectiveness
Return on Equity n.a.
Return on Assets -31.00
Return on Investments -38.00
Profitability
Gross Margin 99.40
EBIT Margin n.a.
Profit Margin -94.80

Portfolios with VRTX

Latest VRTX Headlines from TheStreet

More Financial News for VRTX

Press Releases for VRTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter